Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 50090-7680

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 50090-7680). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907680)

Label Image (Lbl500907680)
Label of OLMESARTAN MEDOXOMIL 40 mg film-coated tablets by A-S Medication Solutions. The label states each tablet contains 40 mg of olmesartan medoxomil and instructs storage below 77 degrees Fahrenheit. The package contains 30 tablets. The product NDC 50090-7680 is visible along with a QR code and dispensing instructions indicating prescription only.*
FDA Label Image

Logo0001-01 (Logo0001 01)

FDA Label Image

Chemical Structure (Olmesartan Medoxomil Figure 1)

Chemical Structure (Olmesartan Medoxomil Figure 1)
Chemical structure diagram of olmesartan medoxomil, showing the detailed molecular arrangement and bonds between atoms in the compound.*
FDA Label Image

Figure (Olmesartan Medoxomil Figure 2)

Figure (Olmesartan Medoxomil Figure 2)
A dose-response line graph depicting the placebo-adjusted reduction in blood pressure (mmHg) for Olmesartan Medoxomil. The x-axis shows Olmesartan Medoxomil dose in mg ranging from 0 to 100. The y-axis shows reduction in blood pressure in mmHg from 0 to 14. Two lines represent systolic and diastolic blood pressure reductions, with systolic reductions consistently higher across doses.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.